Application of serex-analysis for identification of human colon cancer antigens

Background: Colorectal, lung and breast tumors are the most devastating and frequent malignances in clinical oncology. SEREX-analysis of colon cancer leads to identification of more than hundred antigens which are potential tumor markers. With idea that immunoscreening with pool of allogeneic sera i...

Повний опис

Збережено в:
Бібліографічні деталі
Опубліковано в: :Experimental Oncology
Дата:2015
Автори: Garifulin, O.M., Kykot, V.O., Gridina, N.Y., Kiyamova, R.G., Gout, I.T., Filonenko, V.V.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2015
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/145484
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Application of serex-analysis for identification of human colon cancer antigens / O.M. Garifulin, V.O. Kykot, N.Y. Gridina, R.G. Kiyamova, I.T. Gout, V.V. Filonenko // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 173-180. — Бібліогр.: 46 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-145484
record_format dspace
spelling Garifulin, O.M.
Kykot, V.O.
Gridina, N.Y.
Kiyamova, R.G.
Gout, I.T.
Filonenko, V.V.
2019-01-22T12:47:53Z
2019-01-22T12:47:53Z
2015
Application of serex-analysis for identification of human colon cancer antigens / O.M. Garifulin, V.O. Kykot, N.Y. Gridina, R.G. Kiyamova, I.T. Gout, V.V. Filonenko // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 173-180. — Бібліогр.: 46 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145484
Background: Colorectal, lung and breast tumors are the most devastating and frequent malignances in clinical oncology. SEREX-analysis of colon cancer leads to identification of more than hundred antigens which are potential tumor markers. With idea that immunoscreening with pool of allogeneic sera is more productive for antigen isolation, SEREX-analysis was applied to four cases of stages II–IV primary colon tumor and 22 new antigens were isolated. Objective: To characterize 22 primary colon cancer antigens isolated by SEREX-technique. Materials and Methods: Allogenic screening, real-time PCR analysis. Results: After allogeneic immunoscreening, for 5 of 22 (22%) isolated antigens were confirmed colon cancer restricted serological profile solely positive for 14% of tested colon cancer sera. Through these five antigens, KY-CC-17/β-actin has cytoskeleton function; KY-CC-14/ACTR1A and KY-CC-19/TSGA2 participate in chromosome segregation; KY-CC-12/FKBP4 regulates steroid receptor function and KY-CC-15/PLRG1 is a component of spliceosome complex. For the last four antigens tested were found aberrant mRNA expression in some cases of colon tumor. Conclusion: The exploration of identified antigens may define suitable targets for immunotherapy or diagnostic of colon cancer. Key Words: colon cancer, SEREX-analysis, allogeneic immunoscreening.
We thank Dr. U. Sahin and Dr. O. Tureci at III. Medizinische Klinik and Poliklinik, Johannes Gutenberg Universitat Mainz, Germany, for introduction to us allogeneic SEREX-analysis procedure and help in RT-PCR analysis of cDNAs. This study was supported by Russian Science Foundation (project 15–15–20032).
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Application of serex-analysis for identification of human colon cancer antigens
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Application of serex-analysis for identification of human colon cancer antigens
spellingShingle Application of serex-analysis for identification of human colon cancer antigens
Garifulin, O.M.
Kykot, V.O.
Gridina, N.Y.
Kiyamova, R.G.
Gout, I.T.
Filonenko, V.V.
Original contributions
title_short Application of serex-analysis for identification of human colon cancer antigens
title_full Application of serex-analysis for identification of human colon cancer antigens
title_fullStr Application of serex-analysis for identification of human colon cancer antigens
title_full_unstemmed Application of serex-analysis for identification of human colon cancer antigens
title_sort application of serex-analysis for identification of human colon cancer antigens
author Garifulin, O.M.
Kykot, V.O.
Gridina, N.Y.
Kiyamova, R.G.
Gout, I.T.
Filonenko, V.V.
author_facet Garifulin, O.M.
Kykot, V.O.
Gridina, N.Y.
Kiyamova, R.G.
Gout, I.T.
Filonenko, V.V.
topic Original contributions
topic_facet Original contributions
publishDate 2015
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Background: Colorectal, lung and breast tumors are the most devastating and frequent malignances in clinical oncology. SEREX-analysis of colon cancer leads to identification of more than hundred antigens which are potential tumor markers. With idea that immunoscreening with pool of allogeneic sera is more productive for antigen isolation, SEREX-analysis was applied to four cases of stages II–IV primary colon tumor and 22 new antigens were isolated. Objective: To characterize 22 primary colon cancer antigens isolated by SEREX-technique. Materials and Methods: Allogenic screening, real-time PCR analysis. Results: After allogeneic immunoscreening, for 5 of 22 (22%) isolated antigens were confirmed colon cancer restricted serological profile solely positive for 14% of tested colon cancer sera. Through these five antigens, KY-CC-17/β-actin has cytoskeleton function; KY-CC-14/ACTR1A and KY-CC-19/TSGA2 participate in chromosome segregation; KY-CC-12/FKBP4 regulates steroid receptor function and KY-CC-15/PLRG1 is a component of spliceosome complex. For the last four antigens tested were found aberrant mRNA expression in some cases of colon tumor. Conclusion: The exploration of identified antigens may define suitable targets for immunotherapy or diagnostic of colon cancer. Key Words: colon cancer, SEREX-analysis, allogeneic immunoscreening.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/145484
citation_txt Application of serex-analysis for identification of human colon cancer antigens / O.M. Garifulin, V.O. Kykot, N.Y. Gridina, R.G. Kiyamova, I.T. Gout, V.V. Filonenko // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 173-180. — Бібліогр.: 46 назв. — англ.
work_keys_str_mv AT garifulinom applicationofserexanalysisforidentificationofhumancoloncancerantigens
AT kykotvo applicationofserexanalysisforidentificationofhumancoloncancerantigens
AT gridinany applicationofserexanalysisforidentificationofhumancoloncancerantigens
AT kiyamovarg applicationofserexanalysisforidentificationofhumancoloncancerantigens
AT goutit applicationofserexanalysisforidentificationofhumancoloncancerantigens
AT filonenkovv applicationofserexanalysisforidentificationofhumancoloncancerantigens
first_indexed 2025-12-07T17:58:13Z
last_indexed 2025-12-07T17:58:13Z
_version_ 1850873262567849984